Fiber Therapy
NDC Package 63868-169-90

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Fiber Therapy is take this product (child or adult dose)  with a full glass or water (8oz.) or other fluid. Marketed by Chain Drug Marketing Association Inc., this product is identified by NDC 63868-169 and is authorized under FDA application part334.

Identification & Billing

NDC Package Code
63868-169-90
Package Description
90 TABLET in 1 BOTTLE
Product Code
63868-169
11-Digit Billing Format
63868016990
Billing Unit
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
Units Per Package
90 EA
RxNorm Crosswalk
  • RxCUI: 308934 - calcium polycarbophil 625 MG Oral Tablet
  • RxCUI: 308934 - calcium polycarbophil 625 MG (as polycarbophil 500 MG) Oral Tablet

Clinical Specifications

Proprietary Name
Fiber Therapy
Dosage Form
-
Usage Information
Take this product (child or adult dose)  with a full glass or water (8oz.) or other fluid. Taking this product without enough liquid may cause chocking. See choking warning.dosage will vary according to diet, exercise, previous laxative use or severity of constipationcontinued use for 1 to 3 days is normally required to provide full benefitadults and children 12 years and over2 caplets, 1 to 4 times a day  children under 12 years  ask a doctor

Regulatory & Marketing

Labeler Name
Chain Drug Marketing Association Inc.
FDA Application #
part334
Marketing Category
OTC MONOGRAPH NOT FINAL - A product marketed pursuant to an Over-the-Counter (OTC) Drug Monograph that is not final.
Start Marketing Date
08-15-2022
Listing Expiration
12-31-2024
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 63868-169-90 identifies a specific commercial package of 90 tablet in 1 bottle of Fiber Therapy, labeled by Chain Drug Marketing Association Inc.. This product is billed for "EA" each discreet unit and contains an estimated amount of 90 billable units per package. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Chain Drug Marketing Association Inc. on August 15, 2022. The current certification is valid through December 31, 2024.

How is this Chain Drug Marketing Association Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 63868016990. Quantities are measured in per "each", products billed on a per each basis are usually products dispensed in discreet units.. There are 90 total billable units per package. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
63868-169-90
11-Digit CMS (5-4-2)
63868-0169-90

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.